Fluticasone Propionate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada
Published April 29, 2015 · Recall initiated: November 14, 2014
Summary
FDA records drug Class II recall D-690-2015, published April 29, 2015 and initiated November 14, 2014. Recalling firm: Attix Pharmaceuticals; Status: Terminated; Reported quantity: 16770 grams; Lot: All lots repackaged and distributed between 01/05/12 to 02/12/15. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
What to do
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Attix Pharmaceuticals
- Distributor
- Nationwide to compounding pharmacies and research organizations.
- Lot
- All lots repackaged and distributed between 01/05/12 to 02/12/15
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- Canada
Related recalls
- FDAMethyl 5-Aminolevulinate Hydrochloride active pharmaceutical ingredient packaged in varying grams or kg inApril 29, 2015
- FDAHomatropine Methylbromide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums,April 29, 2015
- FDAMethyl Folate Calcium active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, AttixApril 29, 2015
- FDAPancuronium Bromide active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, AttixApril 29, 2015
- FDAFluprostenol active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, AttixApril 29, 2015
- FDAFormoterol Fumarate Dihydrate active pharmaceutical ingredient packaged in varying grams or kg in bags orApril 29, 2015
Questions about this recall
Was Fluticasone Propionate active pharmaceutical ingredient packaged in varying grams or kg in bags or drums, Attix Pharmaceuticals, 184 Front Street East, Unit 801, Toronto, Ontario M5A 4N3, Canada recalled?
Yes. FDA published recall D-690-2015 on April 29, 2015. Reported hazard: Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
What should I do if I have this product?
Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit